CochLear - 16 Year Stock Price History | CHEOY
Historical daily share price chart and data for CochLear since 2009 adjusted for splits and dividends. The latest closing stock price for CochLear as of August 22, 2025 is 98.90.
- The all-time high CochLear stock closing price was 112.00 on July 15, 2024.
- The CochLear 52-week high stock price is 104.47, which is 5.6% above the current share price.
- The CochLear 52-week low stock price is 74.76, which is 24.4% below the current share price.
- The average CochLear stock price for the last 52 weeks is 93.02.
| CochLear Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 90.9854 | 90.4376 | 103.9230 | 75.1800 | 98.9000 | 11.10% |
| 2024 | 101.4100 | 99.6716 | 111.9970 | 89.0162 | 89.0162 | -10.74% |
| 2023 | 78.7557 | 65.5080 | 100.8480 | 65.5080 | 99.7235 | 49.26% |
| 2022 | 69.9347 | 73.9312 | 83.7154 | 55.8788 | 66.8132 | -10.66% |
| 2021 | 79.0936 | 68.6176 | 89.5132 | 65.5608 | 74.7851 | 9.01% |
| 2020 | 66.1240 | 73.4147 | 82.1935 | 43.1590 | 68.6053 | -6.67% |
| 2019 | 64.8959 | 55.9923 | 75.7868 | 54.6836 | 73.5050 | 31.52% |
| 2018 | 63.6476 | 60.0480 | 71.5894 | 52.1165 | 55.8880 | -7.34% |
| 2017 | 52.0668 | 39.4085 | 63.9148 | 39.4085 | 60.3164 | 53.80% |
| 2016 | 38.6701 | 29.9094 | 48.0168 | 27.2446 | 39.2185 | 30.12% |
| 2015 | 27.8868 | 26.9052 | 31.3033 | 24.8434 | 30.1408 | 11.86% |
| 2014 | 24.0673 | 21.4913 | 28.8138 | 19.7255 | 26.9459 | 25.64% |
| 2013 | 24.8604 | 32.7849 | 33.7863 | 20.2357 | 21.4465 | -33.60% |
| 2012 | 26.3853 | 24.4016 | 32.4845 | 22.3938 | 32.2981 | 34.44% |
| 2011 | 26.7805 | 30.0668 | 33.2896 | 16.3274 | 24.0243 | -20.85% |
| 2010 | 25.0558 | 20.2382 | 30.3516 | 20.2382 | 30.3516 | 38.51% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.814B | $1.525B |
| Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.199B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Revvity (RVTY) | United States | $10.928B | 19.25 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Organon (OGN) | United States | $2.451B | 2.67 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| CareDx (CDNA) | United States | $0.690B | 12.72 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.446B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.354B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| ModivCare (MODV) | United States | $0.015B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |